Orbia Advance Corporation, S.A.B. de C.V.

DB:4FZ Stock Report

Market Cap: €1.5b

Orbia Advance Corporation. de Valuation

Is 4FZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 4FZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 4FZ (€0.75) is trading below our estimate of fair value (€2.24)

Significantly Below Fair Value: 4FZ is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 4FZ?

Key metric: As 4FZ is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 4FZ. This is calculated by dividing 4FZ's market cap by their current earnings.
What is 4FZ's PE Ratio?
PE Ratio11.4x
EarningsUS$137.00m
Market CapUS$1.56b

Price to Earnings Ratio vs Peers

How does 4FZ's PE Ratio compare to its peers?

The above table shows the PE ratio for 4FZ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average33.4x
FPE3 Fuchs
18.1x8.6%€4.8b
SIM0 SIMONA
11xn/a€342.0m
SDF K+S
76.8x57.3%€2.0b
WCH Wacker Chemie
27.5x36.4%€3.4b
4FZ Orbia Advance Corporation. de
11.4x5.3%€31.4b

Price-To-Earnings vs Peers: 4FZ is good value based on its Price-To-Earnings Ratio (11.4x) compared to the peer average (33.4x).

Price to Earnings Ratio vs Industry

How does 4FZ's PE Ratio compare vs other companies in the European Chemicals Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
4FZ 11.4xIndustry Avg. 17.0xNo. of Companies12PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 4FZ is good value based on its Price-To-Earnings Ratio (11.4x) compared to the European Chemicals industry average (17x).

Price to Earnings Ratio vs Fair Ratio

What is 4FZ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

4FZ PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio11.4x
Fair PE Ratio15.2x

Price-To-Earnings vs Fair Ratio: 4FZ is good value based on its Price-To-Earnings Ratio (11.4x) compared to the estimated Fair Price-To-Earnings Ratio (15.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 4FZ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€0.75
€1.74
+132.1%
51.7%€4.10€0.76n/a15
Dec ’25€0.86
€2.00
+130.8%
47.6%€4.05€0.96n/a14
Nov ’25€0.82
€2.11
+157.4%
42.4%€3.96€1.05n/a14
Oct ’25€0.94
€2.26
+140.5%
39.0%€3.95€1.02n/a14
Sep ’25€0.99
€2.43
+145.2%
34.6%€4.04€1.42n/a14
Aug ’25€1.21
€2.50
+106.7%
32.3%€4.08€1.73n/a14
Jul ’25€1.30
€2.64
+102.9%
30.7%€4.35€1.77n/a13
Jun ’25€1.52
€2.78
+82.7%
26.2%€4.30€1.94n/a12
May ’25€1.54
€2.92
+89.3%
24.7%€4.36€2.03n/a13
Apr ’25€1.89
€3.02
+59.6%
22.6%€4.32€2.09n/a14
Mar ’25€1.66
€3.01
+81.1%
22.0%€4.30€2.24n/a14
Feb ’25€1.87
€3.02
+61.2%
20.8%€4.51€2.24n/a14
Jan ’25€1.94
€2.99
+54.3%
20.8%€4.48€2.22n/a14
Dec ’24€2.06
€3.00
+45.7%
21.0%€4.51€2.24€0.8614
Nov ’24€1.49
€3.09
+107.7%
20.6%€4.66€2.32€0.8214
Oct ’24€1.97
€3.36
+70.7%
22.2%€5.08€2.32€0.9413
Sep ’24€2.06
€3.31
+60.5%
22.1%€4.99€2.27€0.9913
Aug ’24€2.06
€3.20
+55.5%
22.3%€4.87€2.35€1.2113
Jul ’24€1.98
€3.13
+58.1%
22.3%€4.72€2.36€1.3013
Jun ’24€1.90
€3.12
+64.1%
23.1%€4.65€2.09€1.5213
May ’24€2.06
€3.02
+46.4%
22.6%€4.54€2.04€1.5414
Apr ’24€1.97
€2.96
+50.4%
21.5%€4.50€2.07€1.8914
Mar ’24€1.93
€3.05
+58.3%
21.9%€4.60€2.11€1.6614
Feb ’24€1.80
€2.85
+58.1%
20.8%€4.20€1.87€1.8714
Jan ’24€1.69
€2.85
+68.7%
21.5%€4.30€1.91€1.9414
Dec ’23€1.89
€3.00
+58.6%
16.6%€3.81€2.06€2.0615

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 09:34
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Orbia Advance Corporation, S.A.B. de C.V. is covered by 26 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Federico Robinson Bours CarrilloActinver Case de Bolsa, S.A. de C.V.
Gilberto GarciaBarclays
Pablo Monsivais MendozaBarclays